Drug makers face worst performances in 2Q

Published: 2012-07-04 07:00:00

Updated: 2012-07-04 07:00:00

The country’s eight leading pharmaceutical companies including top-tier ones have struggled to find their feet during the second quarter, even before a government-mandated price cut came into effect.

Market leaders like Dong-A Pharmaceutical, Daewoong Pharmaceutical, Yuhan Corporation and Hanm...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK